Department of Biostatistics, University of Florida, Gainesville, USA.
J Biopharm Stat. 2022 Mar;32(2):298-307. doi: 10.1080/10543406.2021.2009499. Epub 2021 Dec 10.
Interval-censored data occur in a study where the exact event time of each participant is not observed but it is known to be within a certain time interval. Multiple tests were proposed for such data, including the logrank test by Sun, the proportional hazard test by Finkelstein, and the Wilcoxon-type test by Peto and Peto. We propose sample size calculations based on these tests for a parallel one-stage or two-stage design. When the proportional hazard assumption is met, the proportional hazard test and the logrank test need smaller sample sizes than the Wilcoxon-type test, and the sample size savings are substantial. But this trend is reversed when the proportional hazard assumption does not hold, and the sample size savings using the Wilcoxon-type test are sizable. An example from a lung cancer clinical trial is used to illustrate the application of the proposed sample size calculations.
区间删失数据出现在一项研究中,其中每个参与者的确切事件时间未被观察到,但已知在某个时间间隔内。针对此类数据,已经提出了多种检验方法,包括 Sun 的对数秩检验、Finkelstein 的比例风险检验以及 Peto 和 Peto 的 Wilcoxon 型检验。我们针对平行的单阶段或两阶段设计,基于这些检验方法提出了样本量计算方法。当满足比例风险假设时,比例风险检验和对数秩检验所需的样本量小于 Wilcoxon 型检验,并且样本量节省较大。但是,当不满足比例风险假设时,这种趋势会逆转,而使用 Wilcoxon 型检验的样本量节省则较大。本文通过一个肺癌临床试验的实例说明了所提出的样本量计算方法的应用。